Jos Lamers, CEO of Nucletron said, 2011 is the Year of Radiotherapy in the UK, and there is no better location than London for ESTRO to hold this year’s meeting and commemorate its 30th anniversary. Nucletron is proud of our long term partnership with ESTRO, and we’re looking forward to working with the organization and its members to further advance the important role of radiotherapy, in particular brachytherapy, in the multimodality treatment of cancer. Our commitment to product innovation, professional education, and raising awareness of the benefits of brachytherapy – all aimed at ensuring patient access to quality cancer care – will highlight Nucletron’s presence at this year’s meeting,” he added.
Nucletron will feature five innovative products and solutions at this year’s meeting, all of which were developed with the needs of the modern radiotherapy department for speed, efficiency, accuracy and quality in mind. Awareness of brachytherapy will also receive special attention, with the presentation of a range of awa\reness and educational materials.